Evidence map›Paper›PMID 33779389›Full record

Observational studyLupus2021

Fatigue in patients with systemic lupus erythematosus and neuropsychiatric symptoms is associated with anxiety and depression rather than inflammatory disease activity.

Rory C Monahan, Liesbeth Jj Beaart-van de Voorde, Jeroen Eikenboom, Rolf Fronczek, Margreet Kloppenburg, Huub Am Middelkoop, Gisela M Terwindt, Nic Ja van der Wee, Tom Wj Huizinga, Gerda M Steup-Beekman

Open access · hybridAbstract readObservational Study
In one paragraph

Observational study in Lupus, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Anti-fatigue effect of traditional Chinese medicines: A review.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2023
    Review
  11. Article
  12. Article
  13. Psychological Implications to the Therapy of Systemic Lupus Erythematosus.International journal of environmental research and public health · 2022
    Review
  14. Observational
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Rory C MonahanDepartment of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands.ORCID https://orcid.org/0000-0003-2561-7085
Liesbeth Jj Beaart-van de VoordeDepartment of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands.
Jeroen EikenboomDepartment of Internal Medicine, Division of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, the Netherlands.
Rolf FronczekDepartment of Neurology, Leiden University Medical Center, Leiden, the Netherlands.
Margreet KloppenburgDepartment of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands.
Huub Am MiddelkoopDepartment of Neurology, Leiden University Medical Center, Leiden, the Netherlands.
Gisela M TerwindtDepartment of Neurology, Leiden University Medical Center, Leiden, the Netherlands.
Nic Ja van der WeeDepartment of Psychiatry, Leiden University Medical Center, Leiden, the Netherlands.
Tom Wj HuizingaDepartment of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands.
Gerda M Steup-BeekmanDepartment of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands.
Leiden University Medical Center · NLLeiden University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionWe aimed to investigate risk factors for fatigue in patients with systemic lupus erythematosus (SLE) and neuropsychiatric symptoms in order to identify potential interventional strategies.

methodsPatients visiting the neuropsychiatric SLE (NPSLE) clinic of the Leiden University Medical Center between 2007-2019 were included. In a multidisciplinary consensus meeting, SLE patients were classified as having neuropsychiatric symptoms of inflammatory origin (inflammatory phenotype) or other origin (non-inflammatory phenotype). Fatigue was assessed with the SF-36 vitality domain (VT) since 2007 and the multidimensional fatigue inventory (MFI) and visual analogue scale (VAS) since 2011. Patients with a score on the SF-36 VT ≥1 standard deviation (SD) away from the mean of age-related controls of the general population were classified as fatigued; patients ≥2 SD away were classified as extremely fatigued. Disease activity was measured using the SLE disease activity index-2000. The influence of the presence of an inflammatory phenotype, disease activity and symptoms of depression and anxiety as measured by the hospital anxiety and depression scale (HADS) was analyzed using multiple regression analyses corrected for age, sex and education.

results348 out of 371 eligible patients filled in questionnaires and were included in this study . The majority was female (87%) and the mean age was 43 ± 14 years. 72 patients (21%) had neuropsychiatric symptoms of an inflammatory origin. Fatigue was present in 78% of all patients and extreme fatigue was present in 50% of patients with an inflammatory phenotype vs 46% in the non-inflammatory phenotype. Fatigue was similar in patients with an inflammatory phenotype compared to patients with a non-inflammatory phenotype on the SF-36 VT (β: 0.8 (95% CI -4.8; 6.1) and there was less fatigue in patients with an inflammatory phenotype on the MFI and VAS (β: -3.7 (95% CI: -6.9; -0.5) and β: -1.0 (95% CI -1.6; -0.3)). There was no association between disease activity and fatigue, but symptoms of anxiety and depression (HADS) associated strongly with all fatigue measurements.

conclusionThis study suggests that intervention strategies to target fatigue in (NP)SLE patients may need to focus on symptoms of anxiety and depression rather than immunosuppressive treatment.

Indexed as

AdultAnxietyCase-Control StudiesDepressionFatigueFemaleHumansInflammationInterdisciplinary CommunicationLupus Erythematosus, SystemicLupus Vasculitis, Central Nervous SystemMaleMental DisordersMiddle AgedNetherlandsPhenotypefatigueneuropsychiatric lupusSystemic lupus erythematosus

Identifiers

PMID33779389
PMCPMC8120630
OpenAlexW3148004462

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.